The protection of the PAR2 vasodilatation against ANG II-acquired hypertension suggests that endothelial KCa activation by selected membrane receptors could also provide the vasculature with the ability to compensate or replace NO during disease. This evidence concerns the gene F2RL1 and Hypertension.